ABSTRACT
In this chapter, I have reprised the ideas and thinking that went into The Future of Pharma , extending those ideas beyond pharma to medtech and, in places, clarifying issues that have emerged from discussing my work with thousands of industry executives and other experts. I hope it’s not immodest to say that this work has been very well received, with glowing reviews and, importantly for me, enthusiastic endorsements from people who know the industry well.
